Rocket Lab's August Reckoning: A Stock Down 58% Faces Its Defining Moment

Rocket Lab's shares drop sharply despite record Space Force contracts and Neutron progress, signaling a valuation gap as defense and Iridium deals reshape its future.

The gap between what Rocket Lab is achieving and what its share price is saying has rarely been wider. Over the past month, the stock has shed more than a third of its value, closing Friday at EUR 56.30 — a 36.81 percent decline from a month earlier. Yet this sell-off arrives precisely as the company lines up some of the largest contracts in its history and pushes its next-generation rocket toward the launchpad.

The numbers tell a stark story. From the all-time high of EUR 133.80 reached on May 27, 2026, the shares have tumbled nearly 58 percent. The 14-day relative strength index sits at 36.7, a level that technical analysts read as oversold. For a company that has completed more than 90 Electron launches and just logged a successful full-power test of its Archimedes vacuum engine in mid-July, the market's mood seems disconnected from the operational reality.

A Pivot Into Defense

The most significant strategic shift has come from an unexpected direction. A record contract from the U.S. Space Force for suborbital launches positions Rocket Lab as a central player in American missile-defense infrastructure. This follows earlier awards for early-warning and defense satellites, filling an order book that had already reached record levels in the first half of the year. Government contracts of this nature bring revenue visibility that stands in sharp contrast to the stock's annualized volatility of nearly 97 percent.

The market's shrug at the Space Force news may stem from timing — the first launches aren't scheduled until late 2026. But the long-term revenue security these agreements provide suggests a valuation that could be far more stable than the recent price action implies.

The Neutron Question

The real value driver remains the Neutron rocket, and here the picture is more complicated. The first flight from the new Virginia launch site is targeted for the fourth quarter of 2026, though hardware-testing problems in the spring already pushed the schedule back once. A main-tank failure in January had earlier disrupted the timeline, and the arrival of the "Hungry Hippo" fairing at the Virginia spaceport signals hardware is moving toward the pad — but the market appears to be pricing in further delays.

This uncertainty has opened what analysts see as a valuation gap. Investors are weighing Electron's proven reliability against the substantial development costs of the new reusable medium-lift vehicle. The short-term sentiment has found no floor despite the stable launch cadence.

The Iridium Wildcard

The announced acquisition of Iridium Communications marks the company's boldest move yet — a step toward a vertically integrated space structure spanning satellite manufacturing to in-orbit operations. But integrating a multi-billion-euro acquisition carries near-term costs that appear to be eroding confidence, even if the strategic logic is sound. Since the start of the year, the stock is down 8.46 percent, a reminder that even record backlogs don't automatically translate into share-price momentum.

What August 10 Will Tell Us

All eyes now turn to the second-quarter earnings report due August 10, 2026. Three questions dominate: How is revenue tracking against guidance? What's the latest on the Iridium integration? And crucially — does the management team confirm the fourth-quarter window for Neutron's first launch without new hurdles?

The analyst community remains notably optimistic despite a 4.41 percent decline over the past seven days. The average price target stands at EUR 99.22, implying upside of roughly 76.2 percent from current levels. Whether that gap closes depends heavily on the tone of the earnings call. A firm commitment to the Neutron timeline could quickly narrow the distance between price and target. An open-ended answer on the Archimedes test schedule, by contrast, would likely keep the market skeptical about both the Iridium deal and the cost trajectory of the Neutron program.

With a market capitalization of around EUR 35 billion, Rocket Lab finds itself trading between its 52-week low of EUR 32.60 and that May peak of EUR 133.80. The 200-day moving average at EUR 67.37 now serves as notable resistance from above. The August 10 report offers the first hard evidence of whether the dual-engine strategy — launch services plus satellite infrastructure — can justify the valuation the market once assigned it. Until then, the stock remains caught between a broken chart and a business that keeps scaling.